CPH Group Strategically Focuses on Long-Term Growth Sectors

During its Investor Day on September 16, 2025, CPH Group revealed its strategic direction post-Paper business spin-off. The group emphasizes innovation and entry into high-value niches, led by its flagship brands, Zeochem and Perlen Packaging, both holding top-three market positions globally.

The company's sustainable growth strategy aligns with global megatrends in healthcare, aging demographics, and sustainable energy. The Packaging division focuses on the pharmaceutical market, reinforced by the acquisition of LOG Pharma, now expanding into Israeli and Hungarian markets. With a strong market hold, it leads the high-barrier blister sector, a market expected to grow 3%-6% annually.

The Chemistry division, prominent in molecular sieves and deuterated products, reports a 12.5% sales CAGR over five years. Supported by strategic acquisitions like Sorbchem and SiliCycle, the division aims for expansion in resilient segments.

CPH's M&A strategy accentuates disciplined growth to enhance shareholder value. Valuations suggest a favorable long-term outlook with EBITDA margins projected to remain between 16%-18%.